Skip to main content

Table 1 Susceptibility of Salmonella , Shigella sp and diarrheagenic Escherichia coli isolated from stools of patients with acute diarrhea, in Madagascar

From: Antimicrobial resistance of bacterial enteropathogens isolated from stools in Madagascar

  Salmonella sp (n = 84) Shigella sp(n = 164) DiarrheagenicE. coli(n = 195)
Antimicrobial Resistant Intermediate Susceptible Resistant Intermediate Susceptible Resistant Intermediate Susceptible
  N (%) (%) (%) (%) (%) (%) (%) (%) (%)
Amoxicillin 30 (35.7) 0 (0.0) 54 (64.3) 103 (62.8) 0 (0.0) 61 (37.2) 160 (82.1) 0 (0.0) 35 (17.9)
Amoxicillin/Clavulanic acid 2 (2.3) 3 (3.6) 79 (94.1) 12 (7.3) 40 (24.4) 112 (68.3) 2 (1.0) 21 (10.8) 172 (88.2)
Ticarcillin 30 (35.7) 0 (0.0) 54 (64.3) 102 (62.2) 1 (0.6) 61 (37.2) 161 (82.6) 0 (0.0) 34 (17.4)
Cephalothin 2 (2.3) 3 (3.6) 79 (94.1) 14 (8.5) 37 (22.5) 113 (69) 6 (3.1) 11 (5.6) 178 (91.3)
Cefotaxime 1 (1.2) 0 (0.0) 83 (98.8) 0 (0.0) 0 (0.0) 164 (100) 6 (3.1) 0 (0.0) 189 (96.9)
Ceftazidime 1 (1.2) 0 (0.0) 83 (98.8) 0 (0.0) 0 (0.0) 164 (100) 3 (1.5) 3 (1.5) 189 (96.9)
Cefoxitin 0 (0.0) 0 (0.0) 84 (100) 0 (0.0) 0 (0.0) 164 (100) 0 (0.0) 1 (0.5) 194 (99.5)
Gentamicin 0 (0.0) 0 (0.0) 84 (100) 0 (0.0) 0 (0.0) 164 (100) 2 (1.0) 0 (0.0) 193 (99.0)
Nalidixic acid 1 (1.2) 2 (2.3) 81 (96.5) 1 (0.7) 0 (0.0) 163 (99.3) 21 (10.8) 0 (0.0) 174 (89.2)
Ciprofloxacin 0 (0.0) 0 (0.0) 84 (100) 0 (0.0) 0 (0.0) 164 (100) 6 (3.1) 0 (0.0) 189 (96.9)
Trimethoprim/Sulfamethoxazole 2 (2.3) 0 (0.0) 82 (97.7) 131 (79.9) 5 (3.0) 28 (17.1) 165 (84.6) 2 (1.0) 28 (14.4)